康恩贝控股股东拟增持1.999%公司股份

Core Viewpoint - Kang En Bei (600572.SH) announced that its controlling shareholder, Zhejiang Pharmaceutical Group, plans to increase its stake in the company through block trading on the Shanghai Stock Exchange, reflecting confidence in the company's long-term investment value and the need to enhance control [1] Group 1 - Zhejiang Pharmaceutical Group intends to acquire 50.659 million shares, representing 1.999% of the company's total share capital [1] - The share acquisition will occur within three months after the announcement, starting from 15 trading days post-disclosure [1] - Kang En Bei Group Limited, the second-largest shareholder, will be the transferor of shares in this block trading [1]